论文部分内容阅读
按照卫生部与世界卫生组织技术合作备忘录及实施计划,法国蒙得利尔大学布病专家Roux教授,于1979年9月27日来我国进行讲学。 Roux教授做了四次报告:布氏杆菌病的细菌学;人用布氏菌苗的生产与科研;人及动物布病的实验室诊断;布病的流行病学和免疫学,还举行了三次座谈会。通过报告和座谈,Roux教授系统地介绍了他们实验室用石炭酸提取羊型布氏菌不溶性组分(PI)的详细过程及这个组分在人体预防布病的情况。近年,对PI组分又继续分段,提取了4A、IF、SF等有希望的组分。他认为SF组分是具有保护性的主要组分,而且不含肽多糖。而IF是肽多糖组分,4A组分具有较
In accordance with the Memorandum of Understanding on Technical Cooperation between the Ministry of Health and the World Health Organization and the implementation plan, Professor Roux, a brucellosis specialist from the University of Montréal, France, came to China to give lectures on September 27, 1979. Professor Roux made four reports: the bacteriology of brucellosis; the production and research of human brucella vaccine; the laboratory diagnosis of brucellosis in humans and animals; the epidemiology and immunology of brucellosis; Three forums. Through the presentations and discussions, Prof. Roux systematically introduced the detailed process of extracting insoluble fraction (PI) from bovine sheep with carbolic acid in their laboratory and the prevention of brucellosis in this human body. In recent years, the PI component continues to be segmented, extracting 4A, IF, SF and other promising components. He believes that the SF component is a protective main component, and does not contain peptidoglycan. IF is a peptidoglycan component, 4A component has more